Balchem Corporation
NASDAQ:BCPCChemicals - Specialty
+$1.03 today
- Market cap
- $5.36B
- Beta
- 0.83
- P/E (TTM)
- 33.8
- EPS (TTM)
- $4.90
- Dividend yield
- 0.58%
Volume 0.21M
Average 0.21M
BCPC Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Balchem CorporationNASDAQ: BCPC
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue grows in line with its trailing trend
Q3 FY2026 cost of revenue of $184.94M rose 7.5% year over year, behind the +8.3% change in trailing-twelve-month cost of revenue. Sequentially, it rose 2.6% from the prior quarter. Over 3 fiscal years it compounded at +0.2% a year.
Context
- Cost of revenue amounted to 64.3% of revenue in FY2025, down 0.5 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +7.5% toward the trailing-twelve-month pace of +8.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 666.53M USD
- Year-over-year change
- +7.9%
- 4-year CAGR
- +4.6%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 666.53M | +7.9% |
| FY2024 | 2024-12-31 | 617.48M | -0.5% |
| FY2023 | 2023-12-31 | 620.38M | -6.3% |
| FY2022 | 2022-12-31 | 661.91M | +19.1% |
| FY2021 | 2021-12-31 | 555.85M | — |
Cost of Revenue vs competitors
How BCPC compares with its peers on the latest reported figures
- BCPC's LTM Sep 2026 cost of revenue of $704.6M is the lowest of the 11 companies compared; the peer median is $2.2B.
- Its year-over-year change of +8.3% is the 2nd highest of 11, against a peer median of +2.6%.
- Cost of revenue amounts to 63.5% of revenue for BCPC, versus a peer median of 71.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $7.1B | +0.7% | -6.6% | 80.1% | |
| LTM Jun 2026 | $6.23B | -13.5% | -5.7% | 62.5% | |
| LTM Jun 2026 | $5.5B | +1.1% | -5.8% | 76.3% | |
| LTM Aug 2026 | $2.39B | -1.6% | -5.2% | 67.2% | |
| LTM Sep 2026 | $2.32B | +5.3% | -4.3% | 67.9% | |
| LTM Mar 2026 | $2.08B | +7.2% | -4.2% | 88.9% | |
| LTM Jun 2026 | $1.34B | +4.2% | -2.3% | 72.5% | |
| LTM Jun 2026 | $1.3B | -5.9% | -6.5% | 70.6% | |
| LTM Jun 2026 | $1.11B | +5.9% | +4.2% | 65.4% | |
| LTM Sep 2026 | $883.82M | +9.4% | +3.8% | 77.6% | |
| LTM Sep 2026 | $704.6M | +8.3% | +0.2% | 63.5% | |
| Peer median (excluding BCPC) | $2.2B | +2.6% | -4.8% | 71.6% | |
Competitors are the stored peer set for BCPC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 799.02M | 942.36M | 922.44M | 953.68M | 1.04B |
| Cost of Revenue | 555.85M | 661.91M | 620.38M | 617.48M | 666.53M |
| Gross Profit | 243.17M | 280.45M | 302.06M | 336.21M | 370.63M |
| Gross Margin | 30.4% | 29.8% | 32.7% | 35.3% | 35.7% |
| Research & Development | 13.52M | 12.19M | 15.05M | 16.79M | 18.51M |
| Selling, General & Admin | 102.15M | 123.07M | 130.13M | 136.5M | 142.8M |
| Operating Expenses | 115.67M | 135.27M | 142.86M | 153.3M | 152.3M |
| Depreciation & Amortization | 48.88M | 51.85M | 54.94M | 47.97M | 45.69M |
| EBITDA | 176.57M | 195.87M | 214.81M | 230.95M | 254.94M |
| EBITDA Margin | 22.1% | 20.8% | 23.3% | 24.2% | 24.6% |
| Operating Income | 127.5M | 145.19M | 159.19M | 182.91M | 218.33M |
| Operating Margin | 16.0% | 15.4% | 17.3% | 19.2% | 21.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.46M | 10.27M | 22.61M | 16.53M | 10.22M |
| Other Income / Expenses | (2.27M) | (11.44M) | (21.93M) | (16.46M) | (19.3M) |
| Income Before Tax | 125.23M | 133.75M | 137.26M | 166.45M | 199.03M |
| Pre-Tax Margin | 15.7% | 14.2% | 14.9% | 17.5% | 19.2% |
| Income Tax Expense | 29.13M | 28.38M | 28.72M | 37.98M | 44.19M |
| Net Income | 96.1M | 105.37M | 108.54M | 128.48M | 154.85M |
| Net Margin | 12.0% | 11.2% | 11.8% | 13.5% | 14.9% |
| EPS (Basic) | 2.98 | 3.29 | 3.38 | 3.97 | 4.80 |
| EPS (Diluted) | 2.94 | 3.25 | 3.35 | 3.93 | 4.75 |
| Weighted Avg Shares | 32.22M | 32.02M | 32.11M | 32.33M | 32.6M |
| Weighted Avg Shares (Diluted) | 32.67M | 32.39M | 32.45M | 32.72M | 32.6M |
Balchem Corporation
NASDAQ:BCPC
Intrinsic Alpha fair value
Locked
Current Price
$168.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.